How Would the Trump Administration Affect Clinical Trials?

The new Trump Administration will be overseeing clinical drug policy.

The big question is: How will this new administration affect clinical trials?

Clinical trials are rarely influenced by the politics. Most clinical trial rules are fifty years old and well-established as are international standards. .

The Trump Administration has talked about cost reduction of drugs. However, there is not a lot the government can do to affect drug costs.

Government does not contribute to the cost of drugs and there is no fee that you pay to the government to do a clinical trial. Most government regulations are there to protect people involved in the trial.

Regulatory costs go to the FDA and its used to regulate the industry. The smartest step for drug manufacturers is to plan well, know the regulations and obey the protocols.

DLTA, Drug Lifecycle Tracking Application maps the end-to-end drug approval process. It offers a one stop shop to manage Drug Lifecycle and Regulatory Review process. The application includes built-in tasks, durations, dependencies, key milestones and forms to capture relevant meta-data for each step. And DLTA also provides reports to show complete visibility of all drug approval tasks, their priorities and progress. For more information call (240) 753-8282.